Evidence map›Paper›PMID 9710594›Full record

ArticleMolecular and cellular biology1998

Brachyury-related transcription factor Tbx2 and repression of the melanocyte-specific TRP-1 promoter.

S Carreira, T J Dexter, U Yavuzer, D J Easty, C R Goding

Abstract read
In one paragraph

Article in Molecular and cellular biology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 171 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. TBX2, a Novel Regulator of Labour.Medicina (Kaunas, Lithuania) · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Tbx2 is required for the suppression of mesendoderm during early Xenopus development.Developmental dynamics : an official publication of the American Association of Anatomists · 2018
    Article
  12. TBX5: A Key Regulator of Heart Development.Current topics in developmental biology · 2017
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

S CarreiraEukaryotic Transcription Laboratory, Marie Curie Research Institute, Oxted, Surrey RH8 0TL, United Kingdom.
T J Dexter
U Yavuzer
D J Easty
C R Goding
Marie Curie · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous work has demonstrated that two key melanocyte-specific elements termed the MSEu and MSEi play critical roles in the expression of the melanocyte-specific tyrosinase-related protein 1 (TRP-1) promoter. Both the MSEu and MSEi, located at position -237 and at the initiator, respectively, bind a melanocyte-specific factor termed MSF but are also recognized by a previously uncharacterized repressor, since mutations affecting either of these elements result in strong up-regulation of TRP-1 promoter activity in melanoma cells. Here we demonstrate that repression mediated by the MSEu and MSEi also operates in melanocytes. We also report that both the MSEu and MSEi are recognized by the brachyury-related transcription factor Tbx2, a member of the recently described T-box family, and that Tbx2 is expressed in melanocyte and melanoblast cell lines but not in melanoblast precursor cells. Although Tbx2 and MSF each recognize the TRP-1 MSEu and MSEi motifs, it is binding by Tbx-2, not binding by MSF, that correlates with repression. Several lines of evidence tend to point to the brachyury-related transcription factor Tbx2 as being the repressor of TRP-1 expression: both the MSEu and MSEi bind Tbx2, and mutations in either element that result in derepression of the TRP-1 promoter diminish binding by Tbx2; the TRP-1 promoter, but not the tyrosinase, microphthalmia, or glyceraldehyde-3-phosphate dehydrogenase (G3PDH) promoter, is repressed by Tbx2 in cotransfection assays; a high-affinity consensus brachyury/Tbx2-binding site is able to constitutively repress expression of the heterologous IE110 promoter; and a low-affinity brachyury/Tbx2 binding site is able to mediate Tbx2-dependent repression of the G3PDH promoter. Although we cannot rule out the presence of an additional, as yet unidentified factor playing a role in the negative regulation of TRP-1 in vivo, the evidence presented here suggests that Tbx2 most likely is the previously unidentified repressor of TRP-1 expression and as such is likely to represent the first example of transcriptional repression by a T-box family member.

Indexed as

Fetal ProteinsMembrane GlycoproteinsOxidoreductasesPromoter Regions, GeneticProtein BiosynthesisT-Box Domain ProteinsAnimalsBase SequenceBinding SitesBrachyury ProteinConsensus SequenceDNA-Binding ProteinsDNA PrimersGene Expression RegulationMelanocytesMiceBrachyury ProteinDNA-Binding ProteinsDNA PrimersFetal ProteinsMembrane GlycoproteinsOxidoreductasesProteinsRecombinant ProteinsRepressor ProteinsT-Box Domain Protein 2T-Box Domain ProteinsTranscription Factorstyrosinase-related protein-1Tyrp1 protein, mouse

Identifiers

PMID9710594
PMCPMC109095
OpenAlexW2148670691

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.